GitHub is adopting AI-based scanning for its Code Security tool to expand vulnerability detections beyond the CodeQL static analysis and cover more languages and frameworks. The developer ...

“It felt like I had something in it, like if you had a bit of cream or oily substance in your eye,” Shelley Whittaker recalled of her first symptom Toria Sheffield joined the PEOPLE editorial staff in ...

Alice Chawner has had five surgeries since an MRI scan revealed she had a brain tumor after the fall Lexi Lane is a weekend banking writer at PEOPLE. She first joined as a member of the PEOPLE App ...

FORM OF A VERY SPECIAL APP. IF I TOUCH THIS AND THIS, I DON’T FEEL ANYTHING ON THIS SIDE AT ALL. SO THERE’S NO SENSATION. SANDHYA JEJURIKAR HAS NO FEELING ON THE LEFT SIDE OF HER FACE AND NO HEARING ...

Mark Kashef examines how integrating Obsidian, a markdown-based note-taking application, with Claude Code, an AI-driven automation system, can streamline information management. Obsidian’s graph ...

Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study We analyzed 21,364 pathology reports ...

Instead of relying on the Diagnostic and Statistical Manual of Mental Disorders (DSM), which classifies mental disorders using agreed-upon symptoms, the researchers went for a brain-first route. They ...

The oldest brother of an 11-year-old U.S. citizen girl whose treatment for a rare brain tumor was interrupted when her parents were deported to Mexico is attending the State of the Union address ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...

Share on Pinterest A new AI tool may help predict disease risk using brain MRI datasets. Image credit: Tunvarat Pruksachat/Getty Images The wellness of the brain plays an important role in living a ...

Medical image classification is a critical task where precision is paramount. A false negative can delay life-saving treatment, while a false positive can lead to unnecessary stress and procedures.

A central nervous system (CNS) tumor has prompted the FDA to place clinical holds on two Regenxbio gene therapies, including a candidate that is less than two weeks away from an approval decision.